Table of Contents
1. Methodology and Scope
1.1. Methodology
1.1.1. Initial data exploration
1.1.2. Statistical model and forecast
1.1.3. Industry insights and validation
1.1.4. Definitions forecast parameters
1.2. Data sources
1.2.1. Secondary
1.2.2. Primary
2 Market Overview
2.1 Bifidobacterium Longum Introduction
2.2 Market Analysis by Type
2.2.1 0.2g/Piece
2.2.2 0.25g/Piece
2.3 Market Analysis by Applications
2.3.1 Medicine
2.3.2 Others
2.4 Market Analysis by Regions
2.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey)
2.4.1.1 Germany Market States and Outlook (2013-2026)
2.4.1.2 France Market States and Outlook (2013-2026)
2.4.1.3 UK Market States and Outlook (2013-2026)
2.4.1.4 Italy Market States and Outlook (2013-2026)
2.4.1.5 Russia Market States and Outlook (2013-2026)
2.4.1.6 Turkey Market States and Outlook (2013-2026)
2.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran)
2.4.2.1 Saudi Arabia Market States and Outlook (2013-2026)
2.4.2.2 UAE Market States and Outlook (2013-2026)
2.4.2.3 Israel Market States and Outlook (2013-2026)
2.4.2.4 Iran Market States and Outlook (2013-2026)
2.4.3 Africa (South Africa, Nigeria, Egypt and Algeria)
2.4.3.1 South Africa Market States and Outlook (2013-2026)
2.4.3.2 Nigeria Market States and Outlook (2013-2026)
2.4.3.3 Egypt Market States and Outlook (2013-2026)
2.4.3.4 Algeria Market States and Outlook (2013-2026)
2.5 Market Dynamics
2.5.1 Market Opportunities
2.5.2 Market Risk
2.5.3 Market Driving Force
2.6 Market Competition News and Trend
2.6.1 Merger, Consolidation or Acquisition News
2.6.2 Investment or Disinvestment News
2.6.3 New Product Development and Launch
3 EMEA Bifidobacterium Longum Market Competition, by Manufacturer
3.1 EMEA Bifidobacterium Longum Sales and Market Share by Manufacturer (2016-2018)
3.1.1 EMEA Bifidobacterium Longum Sales by Manufacturer (2016-2018)
3.1.2 EMEA Bifidobacterium Longum Sales Market Share by Manufacturer (2016-2018)
3.2 EMEA Bifidobacterium Longum Revenue and Market Share by Manufacturer (2016-2018)
3.2.1 EMEA Bifidobacterium Longum Revenue by Manufacturer (2016-2018)
3.2.2 EMEA Bifidobacterium Longum Revenue Market Share by Manufacturer (2016-2018)
3.3 EMEA Bifidobacterium Longum Price by Manufacturer (2016-2018)
3.4 Market Concentration Rate
3.4.1 Top 3 Bifidobacterium Longum Manufacturer Market Share (2016-2018)
3.4.2 Top 5 Bifidobacterium Longum Manufacturer Market Share (2016-2018)
3.5 Market Competition Trend
4 Manufacturers Profiles
4.1 ATCC Inc
4.1.1 Business Overview
4.1.2 Bifidobacterium Longum Type and Applications
4.1.2.1 Product A
4.1.2.2 Product B
4.1.3 ATCC Inc Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.2 BioGaia AB
4.2.1 Business Overview
4.2.2 Bifidobacterium Longum Type and Applications
4.2.2.1 Product A
4.2.2.2 Product B
4.2.3 BioGaia AB Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.3 Mystic Pharmaceuticals Inc
4.3.1 Business Overview
4.3.2 Bifidobacterium Longum Type and Applications
4.3.2.1 Product A
4.3.2.2 Product B
4.3.3 Mystic Pharmaceuticals Inc Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.4 Hanson Ltd
4.4.1 Business Overview
4.4.2 Bifidobacterium Longum Type and Applications
4.4.2.1 Product A
4.4.2.2 Product B
4.4.3 Hanson Ltd Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.5 Biofodan A/S
4.5.1 Business Overview
4.5.2 Bifidobacterium Longum Type and Applications
4.5.2.1 Product A
4.5.2.2 Product B
4.5.3 Biofodan A/S Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.6 BioCare Copenhagen ApS
4.6.1 Business Overview
4.6.2 Bifidobacterium Longum Type and Applications
4.6.2.1 Product A
4.6.2.2 Product B
4.6.3 BioCare Copenhagen ApS Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.7 Danisco A/S
4.7.1 Business Overview
4.7.2 Bifidobacterium Longum Type and Applications
4.7.2.1 Product A
4.7.2.2 Product B
4.7.3 Danisco A/S Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.8 Danone SA
4.8.1 Business Overview
4.8.2 Bifidobacterium Longum Type and Applications
4.8.2.1 Product A
4.8.2.2 Product B
4.8.3 Danone SA Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.9 Deerland Enzymes Inc.
4.9.1 Business Overview
4.9.2 Bifidobacterium Longum Type and Applications
4.9.2.1 Product A
4.9.2.2 Product B
4.9.3 Deerland Enzymes Inc. Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
5 EMEA Bifidobacterium Longum Market Analysis by Regions
5.1 EMEA Bifidobacterium Longum Sales, Revenue and Market Share by Regions
5.1.1 EMEA Bifidobacterium Longum Sales by Regions (2013-2018)
5.1.2 EMEA Bifidobacterium Longum Revenue by Regions (2013-2018)
5.2 Europe Bifidobacterium Longum Sales and Growth Rate (2013-2018)
5.3 Middle East Bifidobacterium Longum Sales and Growth Rate (2013-2018)
5.4 Africa Bifidobacterium Longum Sales and Growth Rate (2013-2018)
6 Europe Bifidobacterium Longum by Countries, Type, Application and Manufacturers
6.1 Europe Bifidobacterium Longum Sales, Revenue and Market Share by Countries
6.1.1 Europe Bifidobacterium Longum Sales by Countries (2013-2018)
6.1.2 Europe Bifidobacterium Longum Revenue by Countries (2013-2018)
6.1.3 Germany Bifidobacterium Longum Sales and Growth Rate (2013-2018)
6.1.4 France Bifidobacterium Longum Sales and Growth Rate (2013-2018)
6.1.5 UK Bifidobacterium Longum Sales and Growth Rate (2013-2018)
6.1.6 Russia Bifidobacterium Longum Sales and Growth Rate (2013-2018)
6.1.7 Italy Bifidobacterium Longum Sales and Growth Rate (2013-2018)
6.1.8 Turkey Bifidobacterium Longum Sales and Growth Rate (2013-2018)
6.2 Europe Bifidobacterium Longum Sales and Revenue (value) by Manufacturers (2016-2018)
6.2.1 Europe Bifidobacterium Longum Sales by Manufacturers (2016-2018)
6.2.2 Europe Bifidobacterium Longum Revenue by Manufacturers (2016-2018)
6.3 Europe Bifidobacterium Longum Sales and Sales Share by Type (2013-2018)
6.3.1 Europe Bifidobacterium Longum Sales by Type (2013-2018)
6.3.2 Europe Bifidobacterium Longum Sales Share by Type (2013-2018)
6.4 Europe Bifidobacterium Longum Sales and Sales Share by Application (2013-2018)
6.4.1 Europe Bifidobacterium Longum Sales by Application (2013-2018)
6.4.2 Europe Bifidobacterium Longum Sales Share by Application (2013-2018)
7 Middle East Bifidobacterium Longum by Countries, Type, Application and Manufacturers
7.1 Middle East Bifidobacterium Longum Sales, Revenue and Market Share by Countries
7.1.1 Middle East Bifidobacterium Longum Sales by Countries (2013-2018)
7.1.2 Middle East Bifidobacterium Longum Revenue by Countries (2013-2018)
7.1.3 Saudi Arabia Bifidobacterium Longum Sales and Growth Rate (2013-2018)
7.1.4 Israel Bifidobacterium Longum Sales and Growth Rate (2013-2018)
7.1.5 UAE Bifidobacterium Longum Sales and Growth Rate (2013-2018)
7.1.6 Iran Bifidobacterium Longum Sales and Growth Rate (2013-2018)
7.2 Middle East Bifidobacterium Longum Sales and Revenue (value) by Manufacturers (2016-2018)
7.2.1 Middle East Bifidobacterium Longum Sales by Manufacturers (2016-2018)
7.2.2 Middle East Bifidobacterium Longum Revenue by Manufacturers (2016-2018)
7.3 Middle East Bifidobacterium Longum Sales and Sales Share by Type (2013-2018)
7.2.1 Middle East Bifidobacterium Longum Sales by Type (2013-2018)
7.2.2 Middle East Bifidobacterium Longum Sales Share by Type (2013-2018)
7.4 Middle East Bifidobacterium Longum Sales and Sales Share by Application (2013-2018)
7.4.1 Middle East Bifidobacterium Longum Sales by Application (2013-2018)
7.4.2 Middle East Bifidobacterium Longum Sales Share by Application (2013-2018)
8 Africa Bifidobacterium Longum by Countries, Type, Application and Manufacturers
8.1 Africa Bifidobacterium Longum Sales, Revenue and Market Share by Countries
8.1.1 Africa Bifidobacterium Longum Sales by Countries (2013-2018)
8.1.2 Africa Bifidobacterium Longum Revenue by Countries (2013-2018)
8.1.3 South Africa Bifidobacterium Longum Sales and Growth Rate (2013-2018)
8.1.4 Nigeria Bifidobacterium Longum Sales and Growth Rate (2013-2018)
8.1.5 Egypt Bifidobacterium Longum Sales and Growth Rate (2013-2018)
8.1.6 Algeria Bifidobacterium Longum Sales and Growth Rate (2013-2018)
8.2 Middle East Bifidobacterium Longum Sales and Revenue (value) by Manufacturers (2016-2018)
8.2.1 Middle East Bifidobacterium Longum Sales by Manufacturers (2016-2018)
8.2.2 Middle East Bifidobacterium Longum Revenue by Manufacturers (2016-2018)
8.3 Middle East Bifidobacterium Longum Sales and Sales Share by Type (2013-2018)
8.3.1 Middle East Bifidobacterium Longum Sales by Type (2013-2018)
8.3.2 Middle East Bifidobacterium Longum Sales Share by Type (2013-2018)
8.4 Middle East Bifidobacterium Longum Sales and Sales Share by Application (2013-2018)
8.4.1 Middle East Bifidobacterium Longum Sales by Application (2013-2018)
8.4.2 Middle East Bifidobacterium Longum Sales Share by Application (2013-2018)
9 EMEA Bifidobacterium Longum Market Segment by Type
9.1 EMEA Bifidobacterium Longum Sales, Revenue and Market Share by Type (2013-2018)
9.1.1 EMEA Bifidobacterium Longum Sales and Market Share by Type (2013-2018)
9.1.2 EMEA Bifidobacterium Longum Revenue and Market Share by Type (2013-2018)
9.2 EMEA 0.2g/Piece Sales Growth Rate and Price
9.2.1 EMEA 0.2g/Piece Sales Growth Rate (2013-2018)
9.2.2 EMEA 0.2g/Piece Price (2013-2018)
9.3 0.25g/Piece Sales Growth Rate and Price
9.3.1 EMEA 0.25g/Piece Sales Growth Rate (2013-2018)
9.3.2 EMEA 0.25g/Piece Price (2013-2018)
10 EMEA Bifidobacterium Longum Market Segment by Application
10.1 EMEA Bifidobacterium Longum Sales Market Share by Application (2013-2018)
10.2 Medicine Sales Growth Rate (2013-2018)
10.3 Others Sales Growth Rate (2013-2018)
11 EMEA Bifidobacterium Longum Market Forecast (2019-2026)
11.1 EMEA Bifidobacterium Longum Sales, Revenue and Growth Rate (2019-2026)
11.2 Bifidobacterium Longum Market Forecast by Regions (2019-2026)
11.2.1 Europe Bifidobacterium Longum Market Forecast by Regions (2019-2026)
11.2.1.1 Germany Bifidobacterium Longum Sales Forecast 2019-2026
11.2.1.2 France Bifidobacterium Longum Sales Forecast 2019-2026
11.2.1.3 UK Bifidobacterium Longum Sales Forecast 2019-2026
11.2.1.4 Russia Bifidobacterium Longum Sales Forecast 2019-2026
11.2.1.5 Italy Bifidobacterium Longum Sales Forecast 2019-2026
11.2.1.6 Turkey Bifidobacterium Longum Sales Forecast 2019-2026
11.2.2 Middle East Market Forecast by Regions (2019-2026)
11.2.2.1 Saudi Arabia Bifidobacterium Longum Sales Forecast 2019-2026
11.2.2.2 Israel Bifidobacterium Longum Sales Forecast 2019-2026
11.2.2.3 UAE Bifidobacterium Longum Sales Forecast 2019-2026
11.2.2.4 Iran Bifidobacterium Longum Sales Forecast 2019-2026
11.2.3 Africa Market Forecast by Regions (2019-2026)
11.2.3.1 South Africa Bifidobacterium Longum Sales Forecast 2019-2026
11.2.3.2 Nigeria Bifidobacterium Longum Sales Forecast 2019-2026
11.2.3.3 Egypt Bifidobacterium Longum Sales Forecast 2019-2026
11.2.3.4 Algeria Bifidobacterium Longum Sales Forecast 2019-2026
11.3 Bifidobacterium Longum Market Forecast by Type (2019-2026)
11.3.1 EMEA Bifidobacterium Longum Sales Forecast by Type (2019-2026)
11.3.2 EMEA Bifidobacterium Longum Market Share Forecast by Type (2019-2026)
11.4 Bifidobacterium Longum Market Forecast by Application (2019-2026)
11.4.1 EMEA Bifidobacterium Longum Sales Forecast by Application (2019-2026)
11.4.2 EMEA Bifidobacterium Longum Market Share Forecast by Application (2019-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Future Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors, Traders and Dealers
12 Research Findings and Conclusion